The Cuban biopharmaceutical industry will present the stipulated dossier to the World Health Organization (WHO) in early March with all the information necessary for the prequalification of its anti-Covid-19 vaccines, Eduardo Martínez, director of BioCubaFarma, reported here.
The CBA-100 product was registered in the Cuban Industrial Property Office, as a supplement and medicine for human and animal use and one hundred percent organic, which was conceived by two people from Holguín during the confrontation with the COVID-19 pandemic in the province.
Read more CBA-100 product with Industrial Property RegistrationPage 176 of 470